Adam R Craig Insider Trading $SNSS Viracta Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Adam R Craig.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Adam R Craig. Adam R Craig is President and CEO in CTI BIOPHARMA CORP ($CTIC) and See Remarks in CTI BIOPHARMA CORP ($CTIC) and EVP, Development & CMO in SUNESIS PHARMACEUTICALS INC ($SNSS) and VP and Chief Medical Officer in CytRx Oncology Corp ($NA).

Adam R Craig in Viracta Therapeutics, Inc.

Trading Symbol: SNSS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adam R Craig: EVP, Development & CMO
Holdings: 23,452 shares
Current Value: $96,153
Latest Transaction: Mar 02 2015
$SNSS Market Capitalization: $85.18M
$SNSS Previous Close: $4.10

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Adam R Craig in Viracta Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CTIC, NA, SNSS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 02 2015SNSSSUNESIS PHARMACEUT ...Craig Adam REVP, Development & ...Payment of ExerciseF2.228,30218,43023,45231.8 K to 23.5 K (-26.14 %)
Mar 02 2015SNSSSUNESIS PHARMACEUT ...Craig Adam REVP, Development & ...GrantA0.0019,031031,75412.7 K to 31.8 K (+149.58 %)

Page:   1